Company Directory > Biotech > Hevolution Foundation
Hevolution Foundation is a global non-profit organization headquartered in Riyadh, Saudi Arabia, dedicated to extending the healthy human lifespan (healthspan) and advancing the field of geroscience. Established by a Saudi Royal Decree, the foundation operates as a catalyst, partner, and convener, providing significant grants and early-stage investments to incentivize independent research and entrepreneurship in aging biology. It aims to shift the global healthcare paradigm from reactive disease treatment to proactive prevention by treating aging as a modifiable biological process. With an unprecedented annual budget of up to $1 billion, Hevolution is the world's largest philanthropic funder of healthspan research. The organization supports a global ecosystem of scientists and biotech companies, focusing on accelerating the development of therapeutics that target the underlying hallmarks of aging. Beyond funding, Hevolution hosts major international events like the Global Healthspan Summit to align policymakers, researchers, and investors toward a shared vision of equitable and accessible longevity solutions.
CLASSIFICATION
Company Type:Biotech
Industry:Biotechnology
Sub-Industry:Geroscience and Longevity
SIZE & FINANCIALS
Employees:51-200
Revenue:$1B (Annual Budget)
Founded:2018
Ownership:nonprofit
Status:operating
FUNDING
Stage:Government-backed / Nonprofit
Total Raised:$1000M
Investors:Government of Saudi Arabia, Public Investment Fund (PIF)
PIPELINE
Stage:Discovery
Lead Drug Stage:Phase 1 (via funded partners)
Modalities:Small molecule, mTORC1 inhibitors, Mitophagy inducers, Senotherapeutics, AI-driven drug discovery
Active Trials:4
Trial Phases:Phase 1: 2
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Hevolution Foundation US (Boston Hub)
Key Partnerships:XPRIZE ($101M Healthspan competition), Buck Institute for Research on Aging ($21M partnership), American Federation for Aging Research (AFAR), King Saud University ($40M donation), FII Institute
COMPETITION
Position:Leader
Competitors:Altos Labs, Calico Life Sciences, Life Biosciences, Longevity Science Foundation, Apollo Health Ventures
LEADERSHIP
Key Executives:
Dr. Mehmood Khan - CEO
HRH Princess Dr. Haya Bint Khaled Bin Bandar Al Saud - Vice Chair / Science Executive
Dr. William Greene - Chief Investment Officer
Board Members:HRH Prince Mohammed bin Salman (Chairman), Yasir Al-Rumayyan (Governor of PIF), Andrew N. Liveris (Former CEO of Dow Chemical), Ronald Burkle (Yucaipa Companies), Lord Evgeny Lebedev
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Hevolution Foundation. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.